Shannon L. Devers, the EVP of $IONS, sold 3,460 shares of the company on 01-07-2026 for an estimated $292,785. We received data on the trade from a recent SEC filing. This was a sale of approximately 16.5% of their shares of this class of stock. Following this trade, they now own 17,494 shares of this class of $IONS stock.
$IONS Insider Trading Activity
$IONS insiders have traded $IONS stock on the open market 92 times in the past 6 months. Of those trades, 0 have been purchases and 92 have been sales.
Here’s a breakdown of recent trading of $IONS stock by insiders over the last 6 months:
- RICHARD S GEARY (EVP, Chief Development Officer) has made 0 purchases and 12 sales selling 203,468 shares for an estimated $14,161,179.
- PATRICK R. O'NEIL (EVP CLO & General Counsel) has made 0 purchases and 12 sales selling 216,005 shares for an estimated $13,811,605.
- BRETT P MONIA (Chief Executive Officer) has made 0 purchases and 6 sales selling 207,843 shares for an estimated $12,482,827.
- JOSEPH H WENDER has made 0 purchases and 13 sales selling 128,800 shares for an estimated $8,660,121.
- SHANNON L. DEVERS (EVP, Chief Human Resources Ofc) has made 0 purchases and 9 sales selling 71,401 shares for an estimated $5,841,599.
- ERIC SWAYZE (EVP Research) has made 0 purchases and 8 sales selling 68,609 shares for an estimated $4,679,550.
- JOSEPH III KLEIN has made 0 purchases and 5 sales selling 68,000 shares for an estimated $4,320,000.
- JOSEPH BAROLDI (EVP, Chief Business Officer) has made 0 purchases and 6 sales selling 61,625 shares for an estimated $3,837,493.
- ELIZABETH L HOUGEN (EVP, Finance & CFO) sold 49,800 shares for an estimated $3,249,733
- JOAN E HERMAN has made 0 purchases and 2 sales selling 44,000 shares for an estimated $3,173,830.
- C FRANK BENNETT (EVP, Chief Scientific Officer) has made 0 purchases and 4 sales selling 54,909 shares for an estimated $3,098,620.
- BRIAN BIRCHLER (EVP, Corp and Development Ops) has made 0 purchases and 3 sales selling 31,900 shares for an estimated $2,333,366.
- JOSEPH LOSCALZO has made 0 purchases and 2 sales selling 32,000 shares for an estimated $2,164,040.
- EUGENE SCHNEIDER (EVP, Chf Clinical Develop Ofcr) has made 0 purchases and 3 sales selling 29,207 shares for an estimated $1,604,121.
- B LYNNE PARSHALL has made 0 purchases and 5 sales selling 30,000 shares for an estimated $1,586,665.
- ALLENE M. DIAZ sold 1,427 shares for an estimated $60,687
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IONS Hedge Fund Activity
We have seen 249 institutional investors add shares of $IONS stock to their portfolio, and 155 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,891,792 shares (-18.0%) from their portfolio in Q3 2025, for an estimated $189,181,032
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 2,485,000 shares (-65.4%) from their portfolio in Q3 2025, for an estimated $162,568,700
- DEERFIELD MANAGEMENT COMPANY, L.P. added 1,979,669 shares (+inf%) to their portfolio in Q3 2025, for an estimated $129,509,945
- BVF INC/IL removed 1,913,385 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $125,173,646
- MILLENNIUM MANAGEMENT LLC removed 1,869,957 shares (-70.6%) from their portfolio in Q3 2025, for an estimated $122,332,586
- BELLEVUE GROUP AG removed 1,608,747 shares (-20.5%) from their portfolio in Q3 2025, for an estimated $105,244,228
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 1,517,260 shares (+191.8%) to their portfolio in Q3 2025, for an estimated $99,259,149
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$IONS Revenue
$IONS had revenues of $156.7M in Q3 2025. This is an increase of 17.12% from the same period in the prior year.
You can track IONS financials on Quiver Quantitative's IONS stock page.
$IONS Analyst Ratings
Wall Street analysts have issued reports on $IONS in the last several months. We have seen 12 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/10/2025
- Piper Sandler issued a "Overweight" rating on 11/04/2025
- Needham issued a "Buy" rating on 10/30/2025
- Barclays issued a "Overweight" rating on 10/30/2025
- RBC Capital issued a "Outperform" rating on 10/30/2025
- TD Cowen issued a "Buy" rating on 10/30/2025
- Morgan Stanley issued a "Overweight" rating on 10/30/2025
To track analyst ratings and price targets for $IONS, check out Quiver Quantitative's $IONS forecast page.
$IONS Price Targets
Multiple analysts have issued price targets for $IONS recently. We have seen 21 analysts offer price targets for $IONS in the last 6 months, with a median target of $90.0.
Here are some recent targets:
- Yanan Zhu from Wells Fargo set a target price of $100.0 on 01/05/2026
- Luca Issi from RBC Capital set a target price of $95.0 on 12/17/2025
- Mani Foroohar from Leerink Partners set a target price of $100.0 on 12/15/2025
- Jason Gerberry from B of A Securities set a target price of $97.0 on 12/09/2025
- Mitchell S. Kapoor from HC Wainwright & Co. set a target price of $110.0 on 11/10/2025
- Allison Bratzel from Piper Sandler set a target price of $77.0 on 11/04/2025
- Joseph Stringer from Needham set a target price of $90.0 on 10/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
